-
High-Gradient "Moderate" Aortic Stenosis: Is it Moderate or Severe? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-02-01 William A Zoghbi
-
Imaging Topic of the Year: Who Were the Frontrunners in 2024? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-02-01 Thomas H Marwick,Y Chandrashekhar
-
High-Risk Lesion-Level Physiology and Morphology: A Marriage With Unhappy Ending… JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-08 Amir Ahmadi MD, Jagat Narula MD PhD
-
Detecting Hemorrhagic Myocardial Infarction With 3.0-T CMR: Insights Into Spatial Manifestation, Time-Dependence, and Optimal Acquisitions. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-06 Yinyin Chen,Hang Jin,Xingming Guan,Hsin-Jung Yang,Xinheng Zhang,Zhenhui Chen,Shing Fai Chan,Dhirendra Singh,Nithya Jambunathan,Khalid Youssef,Keyur P Vora,Gabriel Gruionu,Sanjana K Dharmakumar,Glen Schmeisser,Richard Tang,Mengsu Zeng,Rohan Dharmakumar
BACKGROUND Hemorrhagic myocardial infarction (hMI) can rapidly diminish the benefits of reperfusion therapy and direct the heart toward chronic heart failure. T2∗ cardiac magnetic resonance (CMR) is the reference standard for detecting hMI. However, the lack of clarity around the earliest time point for detection, time-dependent changes in hemorrhage volume, and the optimal methods for detection can
-
Coronary Artery Calcium Scoring Improves Allocation of the GLP-1 Receptor Agonist Semaglutide. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-03 Robert A Kloner,Matthew J Budoff
-
The Last Decade in Cardiac Amyloidosis: Advances in Understanding Pathophysiology, Diagnosis and Quantification, Prognosis, Treatment Strategies, and Monitoring Response. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-03 Marianna Fontana,Adam Ioannou,Sarah Cuddy,Sharmila Dorbala,Ahmad Masri,James C Moon,Vasvi Singh,Olivier Clerc,Mazen Hanna,Fredrick Ruberg,Martha Grogan,Michele Emdin,Julian Gillmore
Cardiac amyloidosis represents a unique disease process characterized by amyloid fibril deposition within the myocardial extracellular space. Advances in multimodality cardiac imaging enable accurate diagnosis and facilitate prompt initiation of disease-modifying therapies. Furthermore, rapid advances in multimodality imaging have enriched understanding of the underlying pathogenesis, enhanced prognostication
-
Allocation of Semaglutide According to Coronary Artery Calcium and BMI: Applying the SELECT Trial to MESA. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-03 Alexander C Razavi,Alexander M Cao Zhang,Zeina A Dardari,Khurram Nasir,Michael Khorsandi,Martin Bødtker Mortensen,Mouaz H Al-Mallah,Michael D Shapiro,Melissa A Daubert,Roger S Blumenthal,Laurence S Sperling,Seamus P Whelton,Michael J Blaha,Omar Dzaye
BACKGROUND Implementation of semaglutide weight loss therapy has been challenging due to drug supply and cost, underscoring a need to identify those who derive the greatest absolute benefit. OBJECTIVES Allocation of semaglutide was modeled according to coronary artery calcium (CAC) among individuals without diabetes or established atherosclerotic cardiovascular disease (CVD). METHODS In this analysis
-
Ironing It Out: Unraveling the Mysteries of Hemorrhage Post Myocardial Infarction With Cardiac MRI. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-03 Kevin Kai Li,Michael Salerno
-
Molecular Stratification of Light-Chain Cardiac Amyloidosis With 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic Precision. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-03 Xuezhu Wang,Kaini Shen,Yuke Zhang,Yajuan Gao,Bowei Liu,Yubo Guo,Chao Ren,Zhenghai Huang,Xiao Li,Long Chang,Haiyan Ding,Hui Zhang,Zhuang Tian,Marcus Hacker,Shuyang Zhang,Yining Wang,Jian Li,Xiang Li,Li Huo
BACKGROUND Cardiac involvement in amyloid light chain (AL) amyloidosis significantly influences prognosis, necessitating timely diagnosis and meticulous risk stratification. OBJECTIVES This prospective study aimed to delineate the molecular phenotypes of AL cardiac amyloidosis (AL-CA) by characterizing fibro-amyloid deposition using 18F-florbetapir and gallium-68-labeled fibroblast activation protein
-
AI and Echocardiography: Are Valves the Next Frontier? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-01 Partho P Sengupta,Y Chandrashekhar
-
Carotid Artery Atherosclerosis Is a Marker for Risk of Stroke and Cardiac Death. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-01 Christopher K Zarins
-
Time Interval Between Onset of Illness and Imaging in Patients With Takotsubo Syndrome: Pathophysiologic Connotations. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-01 John E Madias
-
Optimizing Medical Therapy Following Cardiac Imaging: Time to Lift Our Game? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-01 Ron Blankstein,Siddharth J Trivedi
-
Realizing the Untapped Potential of Stress Perfusion CMR in Medicare's Aging Population. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-01 Amedeo Chiribiri,Muhummad Sohaib Nazir
-
Reply: Time Interval Between Onset of Illness and Imaging in Patients With Takotsubo Syndrome: Pathophysiologic Connotations. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2025-01-01 Davide Di Vece,Michele Bellino,Angelo Silverio,Mario Cristiano,Rodolfo Citro
-
Our Quest for the Holy Grail in Coronary Artery Disease. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-10 Armin Arbab-Zadeh
-
Prognostic Impact of Diaphragm Thickness in Geriatric Patients With Heart Failure: The SONIC-HF Multicenter Registry. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-06 Nobuyuki Kagiyama,Kentaro Kamiya,Misako Toki,Hiroshi Saito,Kentaro Iwata,Yuya Matsue,Kenji Yoshioka,Kazuya Saito,Takeshi Kitai,Emi Maekawa
-
The Complex Relationship Between Risk Factor Exposure and Coronary Epicardial as Well as Microvascular Disease JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-04 João A.C. Lima MD, Joanne D. Schuijf PhD
-
Imaging and Precision Medicine: The End of the Road for "Lumpers?" JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Thomas H Marwick,Y Chandrashekhar
-
Revisiting Diagnostic Criteria for Hypertrophic Cardiomyopathy in Hypertensive and Nonhypertensive Patients. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Yong-Huai Wang,Chun-Yan Ma
-
Harnessing SGLT2 Inhibitors: A New Frontier in Cardiac Remodeling for Nondiabetic Heart Failure. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Cindy M Martin
-
Quantitative Myocardial Perfusion Imaging: A Case of "More Than Meets the Eye?" JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-12-01 Kim A Connelly,Yin Ge
-
Coronary Artery Calcium Distribution and Cardiovascular Risk: MESA. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-27 Tara Shrout Allen,Mikaila Reyes,Jonathan M Kermanshahchi,Julie O Denenberg,Joseph Yeboah,Matthew A Allison,Michael H Criqui,Harpreet S Bhatia
-
Long-Term Treatment With Mavacamten and Improved Left Atrial Strain in Obstructive Hypertrophic Cardiomyopathy. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-26 Hyun-Jung Lee,Geu-Ru Hong
-
Leveraging a Vision Transformer Model to Improve Diagnostic Accuracy of Cardiac Amyloidosis With Cardiac Magnetic Resonance. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-22 Joshua Cockrum,Makiya Nakashima,Carl Ammoury,Diane Rizkallah,Joseph Mauch,David Lopez,David Wolinksy,Tae Hyun Hwang,Samir Kapadia,Lars G Svensson,Richard Grimm,Mazen Hanna,W H Wilson Tang,Christopher Nguyen,David Chen,Deborah Kwon
BACKGROUND Cardiac magnetic resonance (CMR) imaging is an important diagnostic tool for diagnosis of cardiac amyloidosis (CA). However, discrimination of CA from other etiologies of myocardial disease can be challenging. OBJECTIVES The aim of this study was to develop and rigorously validate a deep learning (DL) algorithm to aid in the discrimination of CA using cine and late gadolinium enhancement
-
Mechanism and Impact of Left Atrial Dyssynchrony on Long-Term Clinical Outcome During Cardiac Resynchronization Therapy JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-20 Lars-Egil R. Hammersboen MD, Marie Stugaard MD PhD, Alexis Puvrez MD, Camilla K. Larsen MD PhD, Espen W. Remme MSc PhD, Erik Kongsgård MD PhD, Jürgen Duchenne MSc PhD, Elena Galli MD PhD, Faraz H. Khan MD, Ole Jakob Sletten MD, Martin Penicka MD PhD, Erwan Donal MD PhD, Jens-Uwe Voigt MD PhD, Otto A. Smiseth MD PhD, John M. Aalen MD PhD
Left bundle branch block (LBBB) causes left atrial (LA) dyssynchrony. It is unknown if LA dyssynchrony impacts long-term prognosis.
-
Parsing the Shades of Gray of Myocardial Fibrosis in Aortic Stenosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-06 Tom Kai Ming Wang MBChB MD, Tiffany Dong MD
-
-
-
Cancer and the Heart: What Do We Really Know About Imaging? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-04 Paaladinesh Thavendiranathan MD SM, Y. Chandrashekhar MD
-
Improving Precision and Refining Risk Prediction of CTRCD With Cardiovascular CT JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-11-04 Purvi J. Parwani MBBS MPH, Juan Lopez-Mattei MD
-
Echocardiographic Evaluation of Chronic Aortic Regurgitation: Comparison With Cardiac Magnetic Resonance and Implications for Guideline Recommendations. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-30 Rowa Attar,Maan Malahfji,Clara Angulo,Duc T Nguyen,Edward A Graviss,Dipan J Shah,William A Zoghbi
BACKGROUND Guidelines for echocardiographic evaluation of aortic regurgitation (AR) have not been validated against an independent quantitative standard. OBJECTIVES The aim of this study was to evaluate the accuracy of the ASE (American Society of Echocardiography) AR guidelines against cardiac magnetic resonance (CMR) and to develop simplified approaches for detection of significant AR. METHODS Patients
-
Coronary Plaque Radiomic Phenotypes Predict Fatal or Nonfatal Myocardial Infarction: Analysis of the SCOT-HEART Trial JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-30 Márton Kolossváry MD PhD, Andrew Lin MBBS BMedSc PhD, Jacek Kwiecinski MD PhD, Sebastien Cadet MS, Piotr J. Slomka PhD, David E. Newby MD PhD, Marc R. Dweck MD PhD, Michelle C. Williams MD PhD, Damini Dey PhD
Coronary computed tomography (CT) angiography–derived attenuation-based plaque burden assessments can identify patients at risk of myocardial infarction.
-
Echocardiographic Markers of Early Left Ventricular Dysfunction in Asymptomatic Aortic Regurgitation: Is It Time to Change the Guidelines? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-29 Vidhu Anand,Hector I Michelena,Christopher G Scott,Alexander T Lee,Vera H Rigolin,Sorin V Pislaru,Garvan C Kane,Juan A Crestanello,Patricia A Pellikka
BACKGROUND The ideal timing for surgery in asymptomatic chronic aortic regurgitation (AR) remains unclear. New thresholds for left ventricular ejection fraction (LVEF), left ventricular (LV) indexed end-systolic volume (iESV), and global longitudinal strain (GLS) have been associated with mortality in these patients. These represent markers of early LV dysfunction. OBJECTIVES The authors sought to
-
Calcium Scoring and Plaque Density: Room for Improvement. JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-26 Harpreet S Bhatia
-
Timing of Regadenoson-Induced Peak Hyperemia and the Effects on Coronary Flow Reserve JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-23 Nathan Kattapuram BS, Shahrad Shadman MD, Eric E. Morgan MD PhD, Charles Benton AS, Stacian Awojoodu DNP, Dong-Yun Kim PhD, Joao Ramos MD PhD, Ana Barac MD PhD, W. Patricia Bandettini MD, Peter Kellman PhD, Gaby Weissman MD, Marcus Carlsson MD PhD
-
Cholesterol, Atherosclerotic, and Inflammatory Risks Among Patients With Statin Therapy JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-23 Neng Dai MD, Yiqing Hu MS, Xianglin Tang MD, WeiFeng Guo MD, Zhenyang Guo MS, Fan Zhou MS, Longjiang Zhang MD, Pranav Prakash Edavi MS, Hao Lu MD, Juying Qian MD, Junbo Ge MD
-
Looking Beyond Stenosis: The Emerging Role of Cardiac CT in Unveiling Microvascular Dysfunction JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-23 Abdul Rahman Ihdayhid MBBS PhD, Nestor Gahungu MD MPhil
-
Stress CMR Perfusion Imaging in the Medicare-Eligible Population: Insights From the SPINS Study JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-16 Yin Ge MD, Panagiotis Antiochos MD, Benedikt Bernhard MD, Bobak Heydari MD, Kevin Steel DO, Scott Bingham MD, J. Ronald Mikolich MD, Andrew E. Arai MD, W. Patricia Bandettini MD, Amit R. Patel MD, Sujata M. Shanbhag, Afshin Farzaneh-Far MD PhD, John F. Heitner MD, Chetan Shenoy MD, Steve W. Leung MD, Jorge A. Gonzalez MD, Dipan J. Shah MD, Subha V. Raman MD, Victor A. Ferrari MD, Jeanette Schulz-Menger
Patients aged ≥65 years account for a disproportionately large portion of cardiovascular (CV) events and pose a challenge for noninvasive detection of coronary artery disease.
-
Right Ventricular Systolic Strain Reference Ranges Across Contemporary Vendor-Neutral Echocardiography Software in Healthy Patients JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-09 Elio Haroun MD, Ankit Agrawal MD, Joseph El Dahdah MD, Tiffany Dong MD, Aro Daniela Arockiam MD, Muhammad Majid MD, Sharmeen Sorathia MD, Richard A. Grimm DO, L. Leonardo Rodriguez MD, Zoran B. Popovic MD PhD, Brian P. Griffin MD, Tom Kai Ming Wang MBChB MD
-
-
-
Calcification vs Inflammation: The Modern Toolkit for Cardiovascular Risk Assessment JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-07 Charalambos Antoniades MD PhD, Kenneth Chan MBBS
-
Evolving Approaches for Diagnostic Testing in Suspected Coronary Artery Disease JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-07 Leslee J. Shaw PhD, Y.S. Chandrashekhar MD DM
-
Impact of Bariatric Surgery on Coronary Microvascular Function: When Lower Weight Means Better Flow! JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-10-02 Paul Poirier MD PhD
-
Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-25 Hyun-Jung Lee MD PhD, Anvesha Singh MBChB PhD, Jaehyun Lim MD, Neil Craig MD, Rong Bing MD, Lionel Tastet PhD, Jun-Bean Park MD PhD, Hyung-Kwan Kim MD PhD, Yong-Jin Kim MD PhD, Marie-Annick Clavel DVM PhD, Bernhard L. Gerber MD PhD, Gerry P. McCann MBChB MD, Marc R. Dweck MD PhD, Phillipe Pibarot DVM PhD, Seung-Pyo Lee MD PhD
Patients with moderate or asymptomatic severe aortic stenosis (AS) are at risk of cardiovascular events.
-
Deep Learning Model of Diastolic Dysfunction Risk Stratifies the Progression of Early-Stage Aortic Stenosis JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-18 Márton Tokodi MD PhD, Rohan Shah MD, Ankush Jamthikar MTech PhD, Neil Craig MD, Yasmin Hamirani MD, Grace Casaclang-Verzosa MD MBA, Rebecca T. Hahn MD, Marc R. Dweck MD PhD, Philippe Pibarot DVM PhD, Naveena Yanamala MSc PhD, Partho P. Sengupta MD DM
The development and progression of aortic stenosis (AS) from aortic valve (AV) sclerosis is highly variable and difficult to predict.
-
Myocardial Blood Flow Quantification Using Stress Cardiac Magnetic Resonance Improves Detection of Coronary Artery Disease JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-18 Shuo Wang MD, Paul Kim MD, Haonan Wang PhD, Ming-Yen Ng BMBS, Andrew E. Arai MD, Amita Singh MD, Saima Mushtaq MD, Tsun Hei Sin BSc, Yuko Tada MD PhD, Elizabeth Hillier MD PhD, Ruyun Jin MD MCR, Christian Østergaard Mariager PhD, Michael Salerno MD PhD, Gianluca Pontone MD, Javier Urmeneta Ulloa PhD, Ibrahim M. Saeed MD, Hena Patel MD, Victor Goh MBBS, Simon Madsen MD, Won Yong Kim MD, Mayil Singram
Myocardial blood flow (MBF) and myocardial perfusion reserve (MPR) using stress cardiovascular magnetic resonance (CMR) have been shown to identify epicardial coronary artery disease. However, comparative analysis between quantitative perfusion and conventional qualitative assessment (QA) remains limited.
-
High-Gradient Aortic Stenosis With Valve Area >1.0 cm2: The “Forgotten” Discordant Hemodynamic Phenotype JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-18 Saki Ito MD MSc, Jae K. Oh MD, Hector I. Michelena MD, Alexander C. Egbe MBBS MPH, Heidi M. Connolly MD, Patricia A. Pellikka MD, Vuyisile T. Nkomo MD MPH, Bradley R. Lewis MSc, William R. Miranda MD
Clinical features and outcomes in severe aortic stenosis (AS) have been described according to the hemodynamic phenotypes.
-
Vascular Remodeling in Coronary Microvascular Dysfunction JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Carlos Collet MD PhD, Koshiro Sakai MD PhD, Takuya Mizukami MD PhD, Hirofumi Ohashi MD PhD, Frederic Bouisset MD, Serena Caglioni MD, Lieven van Hoe MD, Emanuele Gallinoro MD PhD, Dario Tino Bertolone MD, Sofie Pardaens MSc PhD, Sofie Brouwers MD PhD, Tatyana Storozhenko MD, Ruiko Seki MD, Daniel Munhoz MD PhD, Atomu Tajima MD, Dimitri Buytaert MsC, Marc Vanderheyden MD, Eric Wyffels MD, Jozef Bartunek
Approximately one-half of the patients with angina and nonobstructive coronary artery disease (ANOCA) have evidence of coronary microvascular dysfunction (CMD).
-
Fibro-Calcific Imaging: A Step Towards a More Comprehensive Approach to Aortic Valve Pathophysiology? JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Stephanie L. Sellers MSc PhD, David Meier MD
-
Polygenic Risk and the Progression of High-Risk Coronary Plaque JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Nicholas A. Marston MD MPH
-
Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Ana Devesa MD PhD, Valentin Fuster MD PhD, Inés García-Lunar MD PhD, Belén Oliva BSc, Ana García-Alvarez MD PhD, Andrea Moreno-Arciniegas MD, Ravi Vazirani MD, Cristina Pérez-Herreras MD, Pablo Marina PhD, Héctor Bueno MD PhD, Leticia Fernández-Friera MD PhD, Antonio Fernández-Ortiz MD PhD, Javier Sanchez-Gonzalez PhD, Borja Ibanez MD PhD
In patients with ischemic heart disease, coronary microvascular dysfunction is associated with cardiovascular risk factors and poor prognosis; however, data from healthy individuals are scarce.
-
Head-to-Head Comparison of Near-Infrared Spectroscopy–Intravascular Ultrasound and Coronary Computed Tomography Angiography in Assessing Atheroma Characteristics JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Anantharaman Ramasamy MBChB PhD, Francesca Pugliese MD PhD, Ibrahim Halil Tanboga MD PhD, Pieter Kitslaar MSc, Jouke Dijkstra PhD, Anthony Mathur MD PhD, Ryo Torii PhD, James C. Moon MD, Andreas Baumbach PhD MD, Christos V. Bourantas MD PhD
-
Treatment Strategy of Atrial Functional Mitral Regurgitation: Consideration of the Mechanistic Subtypes JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Nobuyuki Kagiyama MD PhD
-
Predictors for Vulnerable Plaque in Functionally Significant Lesions JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Seokhun Yang MD, Doyeon Hwang MD, Koshiro Sakai MD PhD, Takuya Mizukami MD PhD, Jonathon Leipsic MD, Marta Belmonte MD, Jeroen Sonck MD PhD, Bjarne L. Nørgaard MD PhD, Hiromasa Otake MD PhD, Brian Ko MD PhD, Michael Maeng MD PhD, Jesper Møller Jensen MD PhD, Dimitri Buytaert MSc, Daniel Munhoz MD PhD, Daniele Andreini MD PhD, Hirofumi Ohashi MD PhD, Toshiro Shinke MD PhD, Charles A. Taylor PhD, Emanuele
Vulnerable plaque presents prognostic implications in addition to functional significance.
-
Precision Medicine in Ischemic Heart Disease Through Point-of-Care Myocardial Contrast Echocardiography JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Weiting Huang MBBS, Matteo Morello MD, Bethany A. Gholson RCS ACS, Jonathan R. Lindner MD
-
Academic Profile and Gender Representation of Advanced Cardiac Imaging Fellowship Program Directors in the United States JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Vivek Bhat MBBS, Ashish Kumar MD, Ankur Kalra MD MSc, Nandan Anavekar MBBCh, Lauren A. Baldassarre MD, Roosha Parikh MD, Purvi Parwani MBBS MPH
-
Incremental Prognostic Value of Carotid Plaque–RADS Over Stenosis Degree in Relation to Stroke Risk JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Zhe Huang MD, Xue-Qing Cheng MD, Rui-Rui Lu MD, Xiao-Jun Bi MD PhD, Ya-Ni Liu MD PhD, You-Bin Deng MD PhD
Recently, a standardized classification system for carotid atherosclerotic plaques, known as Carotid Plaque–RADS (Reporting and Data System), has been introduced. However, its capacity to improve stroke risk stratification beyond traditional stenosis degree assessment has not been extensively explored.
-
Clinical Utility of LA Indices in Chronic Severe Aortic Regurgitation: A Comes Before V JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-04 Kazuaki Negishi MD PhD MSc, Koya Ozawa MD PhD